Dr. Martin Ostermaier named Pioneer Fellow, InterAx Biotech awarded 150,000 CHF in equity free capital
December 2014, Zürich, Switzerland: InterAx Biotech Co-Founder Martin Ostermaier was selected by a panel of scientific experts as an ETH Zürich Pioneer Fellow. The award was given based on the scientific merit of the arrestin-GPCR complex stabilization technology and its potential in drug screening applications.
